Osteonecrosis of the jaws associated with the use of biphosphonates
DOI:
https://doi.org/10.59334/ROV.v2i25.238Keywords:
Osteonecrosis of the jaws associated with the use of biphosphonates, biphosphonatesAbstract
Osteonecrosis of the jaw induced by bisphosphonates is an undesirable effect associated with long term use of these drugs, is characterized by the presence of exposed and/or necrotic bone in the maxillar and/or mandibular region, which develops in the majority of cases after performing an invasive dental treatment. Many important details about its pathogenesis are still unknown, however there have been established partnerships with certain risk factors. One of the most important aspects related to osteonecrosis of the jaws induced by bisphosphonate is prevention, which currently in Costa Rica is low, therefore there is a clear need for training health professionals in the subject.
Downloads
References
AAOMS (2007). American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg. 65: 369-376. https://doi.org/10.1016/j.joms.2006.11.003
Allen, M y Ruggiero, S. (2011). Osteonecrosis of the Jaw: Recent Clinical and Preclinical Advances. IBMS BoneKey. 8: 141-153. https://doi.org/10.1138/20110500
Barquero, J. (2014). Osteonecrosis de los maxilares inducida por bifosfonatos: análisis del conocimiento de esta reacción adversa por parte de odontólogos y farmacéuticos en Cartago, en el período comprendido entre mayo y junio de 2014. Tesis de Licenciatura en Farmacia. Universidad Internacional de las Américas. San José, Costa Rica.
Booyapakorn, T. et ál, (2007) Biphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple mieloma and other malignancies. J. oraloncology. 44: 857-869. https://doi.org/10.1016/j.oraloncology.2007.11.012
Dayisoylu, E. et ál. (2013). The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study. Int J Oral Maxillofac Surg. 1-6. Disponible en http://www.sciencedirect.com. https://doi.org/10.1016/j.ijom.2013.05.001
Marx, R. (2003). Pamidronate (Aredia) and Zolendronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg. 61: 1115-1157. https://doi.org/10.1016/S0278-2391(03)00720-1
Ohbayashi, Y. et ál (2013). Adjunct teriparatide therapy with monitoring of bone turnover markers and bone scintigraphy for bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol. 115: e31-e37. https://doi.org/10.1016/j.oooo.2012.09.006
Oizumi, T. et ál (2010). Inhibition of Necrotic Actions of Nitrogen-Containing Bisphosphonates (NBPs) and Their Elimination From Bone by Etidronate (a Non-NBP): A Proposal for Possible Utilization of Etidronate as a Substi-tution Drug for NBPs. J Oral Maxillofac Surg. 68:1043-10548. https://doi.org/10.1016/j.joms.2009.08.027
Otto, S. et ál (2010). Bisphosphonate-Related Osteonecrosis of the Jaw: Is pH the Missing Part in the Pathogenesis Puzzle? J Oral Maxillofac Surg. 68:1158-1161. https://doi.org/10.1016/j.joms.2009.07.079
Ruggiero, S. et ál. (2009). American Association of Oral and Maxilofacial Surgeons Position Paper on Biphospho-nate-Related Osteonecrosis of the Jaws – 2009 Update. J Oral Maxillofac Surg. 67: 2-11. https://doi.org/10.1016/j.joms.2009.01.009
Yoneda, T. et ál. (2010). Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxi-llofacial Surgeons. J Bone Miner Metab. 28: 365–383. https://doi.org/10.1007/s00774-010-0162-7
Downloads
Published
Issue
Section
License
Copyright (c) 2016 Juliana Barquero Barrantes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Odontología Vital agree to the following terms:
- Authors retain the copyright and grant Universidad Latina de Costa Rica the right of first publication, with the work simultaneously licensed under a Creative Commons Attribution 4.0 International license (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the Odontología Vital's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
